• Profile
Close

Analysis of patients who decline treatment for squamous cell carcinoma of the head and neck: National perspective

Head & Neck Feb 01, 2020

Sullivan CB, et al. - Using the National Cancer Data Base, which is sponsored by the American Cancer Society and American College of Surgeons, researchers analyzed the demographic and socioeconomic factors of patients at a national level who refuse recommended treatment for squamous cell carcinoma (SCC) of the head and neck. The sample consisted of 166,204 individuals, of which 689 patients declined all treatment. According to this retrospective cohort study, female patients and individuals without insurance, Medicare, or Medicaid may be more likely to decline head and neck SCC recommended treatment. Educational status is not indicative of treatment decline.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay